Results 1 to 10 of about 145,366 (199)
Amikacin: Uses, Resistance, and Prospects for Inhibition
Molecules, 2017 Aminoglycosides are a group of antibiotics used since the 1940s to primarily treat a broad spectrum of bacterial infections. The primary resistance mechanism against these antibiotics is enzymatic modification by aminoglycoside-modifying enzymes that are
Maria Soledad Ramirez +2 more
exaly +3 more sources
The Direction of the Antibacterial Effect of Rutin Hydrate and Amikacin
Antibiotics, 2023 The aim of the presented study was to examine the in vitro antimicrobial activity of rutin hydrate (RH) alone and in combination with amikacin against 12 reference strains of Gram-positive and Gram-negative bacteria.
Maria Miklasińska-Majdanik +2 more
exaly +3 more sources
Microbiology Spectrum, 2021 Ceftazidime-avibactam (CZA) has emerged as a promising solution to the lack of new antibiotics against Pseudomonas aeruginosa infections. Data from in vitro assays of CZA combinations, however, are scarce. The objective of our study was to perform a time-
María M. Montero +12 more
doaj +1 more source
Antibacterial Porous Systems Based on Polylactide Loaded with Amikacin
Molecules, 2022 Three porous matrices based on poly(lactic acid) are proposed herein for the controlled release of amikacin. The materials were fabricated by the method of spraying a surface liquid.
Marta Glinka +7 more
doaj +1 more source
Glucose-Potentiated Amikacin Killing of Cefoperazone/Sulbactam Resistant Pseudomonas aeruginosa
Frontiers in Microbiology, 2022 Multidrug-resistant Pseudomonas aeruginosa has become one of global threat pathogens for human health due to insensitivity to antibiotics. Recently developed reprogramming metabolomics can identify biomarkers, and then, the biomarkers were used to revert
Xi-kang Tang +13 more
doaj +1 more source
Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa
Antibiotics, 2021 Pseudomonas aeruginosa is an opportunistic nosocomial pathogen associated with high morbidity and mortality rates. Combination of antibiotics has been found to combat multi-drug resistant or extensively drug resistance P. aeruginosa.
Sara Mahmoud Farhan +6 more
doaj +1 more source
Review on Population Pharmacokinetics of Amikacin in Paediatrics
Journal of Pure and Applied Microbiology, 2022 Amikacin is an aminoglycoside antibiotic with a broad-spectrum bacterial coverage that is frequently utilized both as monotherapy and in combination with other antibiotics for severe bacterial infections in the paediatric population.
Keerthana Chandrasekar +4 more
doaj +1 more source
Frontiers in Microbiology, 2022 Amikacin and polymyxins as monotherapies are ineffective against multidrug-resistant Acinetobacter baumannii at the clinical dose. When polymyxins, aminoglycosides, and sulbactam are co-administered, the combinations exhibit in vitro synergistic ...
Shixing Zhu +11 more
doaj +1 more source
Antibiotics, 2022 For decades, the spread of multidrug-resistant (MDR) Acinetobacter baumannii has been rampant in critically ill, hospitalized patients. Traditional antibiotic therapies against this pathogen have been failing, leading to rising concerns over management ...
Manas S. Deolankar +5 more
doaj +1 more source
Microorganisms, 2023 Mycobacterium abscessus complex infections are ever on the rise. To curb their increasing evolution, we performed an in-depth study of 43 clinical isolates of cystic fibrosis patients obtained from 2009 to 2020.
Juan Carlos Cao Yao +2 more
doaj +1 more source